Till Örebro universitet

oru.seÖrebro universitets publikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Leptin levels are associated with multiple sclerosis risk
Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden.
Clinical Chemistry, Department of Medical Biosciences, Umeå University, Umeå, Sweden.
Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Neurology, Skåne University Hospital, Malmö, Sweden/Lund and Institution of Clinical Sciences, Neurology, Lund University, Malmö, Sweden.
Visa övriga samt affilieringar
2021 (Engelska)Ingår i: Multiple Sclerosis Journal, ISSN 1352-4585, E-ISSN 1477-0970, Vol. 27, nr 1, s. 19-27Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

BACKGROUND: Obesity early in life has been linked to increased risk of developing multiple sclerosis (MS). Leptin and insulin are both associated with obesity, making them suitable candidates for investigating this connection.

OBJECTIVE: To determine if leptin and insulin are risk factors for relapsing-remitting multiple sclerosis (RRMS).

METHODS: -scored values to calculate odds ratios (ORs) with 95% confidence intervals (CIs).

RESULTS: -score increase was associated with increased risk of MS in individuals younger than 20 years (OR = 1.4, 95% CI = 1.1-1.9) and in all men (OR = 1.4, 95% CI = 1.0-2.0). In contrast, for women aged 30-39 years, there was a lower risk of MS with increased leptin levels (OR = 0.74, 95% CI = 0.54-1.0) when adjusting for insulin levels.

CONCLUSION: We show that the pro-inflammatory adipokine leptin is a risk factor for MS among young individuals.

Ort, förlag, år, upplaga, sidor
Sage Publications, 2021. Vol. 27, nr 1, s. 19-27
Nyckelord [en]
Multiple sclerosis, case–control studies, epidemiology, insulin, leptin, risk factors
Nationell ämneskategori
Endokrinologi och diabetes
Identifikatorer
URN: urn:nbn:se:oru:diva-79934DOI: 10.1177/1352458520905033ISI: 000512269800001PubMedID: 32028836Scopus ID: 2-s2.0-85079468283OAI: oai:DiVA.org:oru-79934DiVA, id: diva2:1394782
Forskningsfinansiär
Vetenskapsrådet, 2015-02419Tillgänglig från: 2020-02-20 Skapad: 2020-02-20 Senast uppdaterad: 2022-09-15Bibliografiskt granskad

Open Access i DiVA

Fulltext saknas i DiVA

Övriga länkar

Förlagets fulltextPubMedScopus

Person

Gunnarsson, Martin

Sök vidare i DiVA

Av författaren/redaktören
Gunnarsson, Martin
Av organisationen
Institutionen för medicinska vetenskaper
I samma tidskrift
Multiple Sclerosis Journal
Endokrinologi och diabetes

Sök vidare utanför DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 228 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf